Treatment costs for advanced prostate cancer using luteinizing hormone-releasing hormone agonists: A solid biodegradable leuprorelin implant versus other formulations

Axel S. Merseburger, Thomas Björk, James Whitehouse, Davide Meani*

*Korrespondierende/r Autor/-in für diese Arbeit
8 Zitate (Scopus)

Fingerprint

Untersuchen Sie die Forschungsthemen von „Treatment costs for advanced prostate cancer using luteinizing hormone-releasing hormone agonists: A solid biodegradable leuprorelin implant versus other formulations“. Zusammen bilden sie einen einzigartigen Fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science